Prothena Article Great article, google" Prothena Sanfrancisco" headline Elan spinoff looks for redemption in protein folding diseases. Prothena is staked by $ 125 million from Elan, a mere 35 employees in 27,550 sq ft at 650 Gateway Blvd, our CEO's hometown. Elan holds 18%, Janssen 15%, Fidelity 10.72%, Invesco 7.32%, Wellinton Mpt, just under 5%. One interview question, do you see Prothena going after protein-folding diseases like Creutzfeld-Jakob disease ? Answered the key issue there is more prevention, though treatment would be fantastic. Looks like a natural fit for Amoriix .this may very well be where they are heading.